Prospective study on the effectiveness assessment of Indocyanine Green Lymphography and Lymphatic Surgery for lymphedema and lymphatic disease.

Prospective study on the effectiveness assessment of Indocyanine Green Lymphography and Lymphatic Surgery for lymphedema and lymphatic disease. - Prospective study on the effectiveness assessment of Indocyanine Green Lymphography and Lymphatic Surgery for lymphedema and lymphatic disease.

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000021762

Enrollment

Registered

2016-04-03

Start date

2016-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lymphedema and lymphatic disease, chylous thoracs and ascites

Interventions

Indocyanine green (ICG) lymphography and Lymphatic venous anastomosis(LVA) Indocyanine green (ICG) lymphography and drug treatment Indocyanine green (ICG) lymphography and radiological treatment

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: All Subjects included in this study are lymphedema and lymphatic disease patients undergoing treatment at our department team (including collaboration with other hospital team) who have been fully informed consented. No age restriction and exclusion criteria were set.

Exclusion criteria

Exclusion criteria: Over 20 y.o.

Design outcomes

Primary

Measure	Time frame
We analyze the assesment pre-operation and after treatment. Patient chart (name, patient ID, clinical history, pre and postoperative course, limb circumference, tissue stiffness); echogram, CT, MRI, lymphoscintigraphy, indocyanine green lymphography, and lymphoangiography obervations; blood test (complete blood count, chemistry, coagulation, blood type); histopathological analysis (collecting lymphatic vessel, adipose tissue, skin tissue, etc.); clinical photography (bilateral upper limbs for upper limb edema, bilateral lower limbs, abdominal, and inguinal area for lower limb lymphedema); health-related QOL analysis using Short Form (SF)-36 Health Survey; patient weight; general physical and image observations.And analysis of chylous and volume of chylous thoracs and ascites.	—

Measure

Time frame

We analyze the assesment pre-operation and after treatment. Patient chart (name, patient ID, clinical history, pre and postoperative course, limb circumference, tissue stiffness); echogram, CT, MRI, lymphoscintigraphy, indocyanine green lymphography, and lymphoangiography obervations; blood test (complete blood count, chemistry, coagulation, blood type); histopathological analysis (collecting lymphatic vessel, adipose tissue, skin tissue, etc.); clinical photography (bilateral upper limbs for upper limb edema, bilateral lower limbs, abdominal, and inguinal area for lower limb lymphedema); health-related QOL analysis using Short Form (SF)-36 Health Survey; patient weight; general physical and image observations.And analysis of chylous and volume of chylous thoracs and ascites.

—

Countries

Japan

Contacts

Public ContactYoshinori Shimizu

Saiseikai Kawaguchi General Hospital Financial and legal department

zaimuhoumu@saiseikai.gr.jp048-253-1551

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026